Brainstorm Cell Therapeutics BCLI
OTC BCLI
$0.77 -0.02 (-2.53%)
As of: Oct 21, 2026 · 11:49 AM EDT

Brainstorm Cell Therapeutics (BCLI) Tax Rate (2010)

Updated

Brainstorm Cell Therapeutics (BCLI) reported Tax Rate of 1.42% for Q4 2010.

Analysis

Brainstorm Cell Therapeutics (BCLI) Tax Rate (2010) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Tax Rate (Qtr)
1 Eli Lilly 1,170.99 Bn 1,139.58 Bn 19.71 Bn 23.27%
2 Johnson & Johnson 642.25 Bn 560.77 Bn 17.26 Bn 17.98%
3 AbbVie 502.08 Bn 475.19 Bn 12.70 Bn 15.47%
4 Merck 375.61 Bn 329.99 Bn 12.21 Bn -
5 Novartis Ag 302.76 Bn 266.75 Bn 11.24 Bn 23.71%
6 Astrazeneca 268.66 Bn 242.35 Bn 12.86 Bn 10.40%
7 Amgen 241.98 Bn 197.38 Bn 7.24 Bn 14.20%
8 Gilead Sciences 193.37 Bn 167.57 Bn 6.22 Bn -
9 Pfizer 172.42 Bn 119.07 Bn 10.94 Bn -
10 Brainstorm Cell Therapeutics 8.50 Mn 8.43 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2010 1.42%
API Access

Brainstorm Cell Therapeutics Tax Rate API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=tax-rate&ticker=BCLI&period=max&api_key=YOUR_API_KEY